Surrozen, Inc.
Status: Publicly traded
Direct answer
Surrozen, Inc. is publicly traded on NASDAQ under the ticker SRZN.
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4...
Can you invest in Surrozen, Inc.?
Yes. Surrozen, Inc. is publicly traded on NASDAQ under the ticker SRZN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Surrozen, Inc.
Detailed equity research is provided by MarketSnap.